Sectors

WAT
Waters Corporation
383.29
1 x 382.94
1 x 383.77
bid
ask
+
3.52
0.93%
11:02 AM
timesize
Ytd 0.91%
1y 8.53%
378.10
day range
384.95
275.05
52 week range
414.15
Open 377.06 Prev Close 379.77 Low 378.10 High 384.95 Mkt Cap 37.62B
Vol 194.85K Avg Vol 1.07M EPS 7.86 P/E 48.74 Forward P/E 22.61
Beta 1.14 Short Ratio 3.42 Inst. Own 99.62% Dividend N/A Div Yield N/A
Ex Div Date 11-26 Earning 07-29 50-d Avg 327.39 200-d Avg 341.19 1yr Est 400.52
Earning
Date For Estimate Reported Surprise surprise %
2026-05-05 2026-03 2.31 2.7 0.39 16.88%
2026-02-09 2025-12 4.5 4.53 0.03 0.67%
2025-11-04 2025-09 3.21 3.4 0.19 5.92%
2025-08-04 2025-06 2.93 2.95 0.02 0.68%
2025-05-06 2025-03 2.22 2.25 0.03 1.35%
2025-02-12 2024-12 4.02 4.1 0.08 1.99%
Upgrade / Downgrade
Date Firm Action From To
2026-06-02 B of A Securities Upgrade Neutral Neutral
2026-05-14 Wells Fargo Upgrade Equal-Weight Equal-Weight
2026-05-07 Barclays Upgrade Overweight Overweight
2026-05-06 UBS Upgrade Neutral Neutral
2026-05-06 JP Morgan Upgrade Neutral Neutral
2026-05-06 TD Cowen Upgrade Hold Hold
Profile
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Insider Holder
Date Name Relation Quantity Description
2026-02-24 BATRA UDIT Chief Executive Officer 36.56K Stock Award(Grant)
2026-02-24 BENNETT JIANQING Officer 7.24K Stock Award(Grant)
2026-02-24 CARPIO ROBERT L III Officer 3.62K Stock Award(Grant)
2026-02-24 CHAUBAL AMOL Chief Financial Officer 8.51K Stock Award(Grant)
2026-03-05 FEARON RICHARD H Director 3.30K Purchase
2026-02-24 HUANG PEARL S. Director 3.28K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Blackrock Inc. 8.54M 3.18B 8.70%
2026-03-30 Vanguard Capital Management LLC 6.38M 2.37B 6.50%
2026-03-30 Vanguard Portfolio Management LLC 4.75M 1.77B 4.84%
2026-03-30 T. Rowe Price Investment Management, Inc. 4.66M 1.73B 4.75%
2026-03-30 Massachusetts Financial Services Co. 4.63M 1.72B 4.72%
2026-03-30 State Street Corporation 4.36M 1.62B 4.44%
Fund Ownership
Report Date Organization Position Value Percentage
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 3.12M 1.16B 3.18%
2026-03-30 T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App 2.75M 1.02B 2.80%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 2.49M 926.94M 2.54%
2026-03-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 2.12M 787.65M 2.16%
2026-04-29 iShares Trust-iShares Core S&P 500 ETF 1.27M 471.62M 1.29%
2026-04-29 Fidelity Concord Street Trust-Fidelity 500 Index Fund 1.26M 467.26M 1.28%
Dividend
Dividend Date
0.16 1996-11-26
Split
Split Date
2 : 1 2000-08-28
2 : 1 1999-06-11